2022-04-04

NJBIZ Conversations: Chris Beddard

Chris Beddard, Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD

Chris Beddard is the Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD.

In this interview with NJBIZ, she speaks about the BD Onclarity™ HPV Assay, an HPV test with extended genotyping that holds the promise of improved outcomes. As long as women use it.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31
Cervical Cancer | Webinars & Videos
ReachMD: The importance of extended genotyping in cervical cancer screening: The special case of HPV 31
Press release: New study finds up to one-third of women receive clinical misdiagnosis of vaginitis
Vaginitis | News & Updates
Press release: New study finds up to one-third of women receive clinical misdiagnosis of vaginitis
Politico article
Cervical Cancer | News & Updates
POLITICO: Women don’t know when to get screened for cervical cancer, survey finds